Sveriges Riksbank
| Bid procedure, 2021-02-01 | |
| Bills | SWEDISH T-BILL: SE0015382064. 2021-04-21 |
| Bid date | 2021-02-01 |
| Bid times | 09.00-10.00 (CET/CEST) on the Bid date |
| Requested volume (corresponding nominal amount) | SE0015382064: 1000 mln SEK +/-500 mln SEK |
| Highest permitted bid volume (corresponding nominal amount) | SE0015382064: 1000 mln SEK per bid |
| Lowest permitted bid volume (corresponding nominal amount) | SEK 50 million per bid |
| Expected allocation time | Not later than 10.15 (CET/CEST) on the Bid date |
| Delivery and payment date | 2021-02-03 |
| Delivery of bills | To the Riksbank's account in Euroclear Sweden AB's securities settlement system 1 4948 6383 |
Stockholm, 2021-01-29
This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Broad Arrow Auctions8.1.2026 10:30:00 CET | Press release
MICHAEL SCHUMACHER’S FIRST F1 GRAND PRIX-WINNING 1992 BENETTON B192-05 TO STAR IN BROAD ARROW’S GLOBAL ICONS: EUROPE ONLINE AUCTION
Alkane Resources Limited8.1.2026 10:22:32 CET | Press release
December 2025 Quarterly Production Update
Onco3R Therapeutics BV8.1.2026 09:00:00 CET | Press release
Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics
Santhera Pharmaceuticals Holding AG8.1.2026 08:16:03 CET | Press release
Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties
CMR Surgical8.1.2026 08:03:26 CET | Press release
CMR Surgical receives CE Mark for use of Versius in paediatric surgery
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
